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1. Introduction 
Adenosine can effect adenylate cyclase in an inhib- 
itory or excitatory manner. These interactions are 
mediated by two distinct classes of sites: 
(i) ‘R sites’ which are sensitive to nM levels of 
adenosine and which can be blocked by methyl 
xanthines. R sites will mediate activation of 
adenylate cyclase in certain tissues [l-5] but 
will mediate inhibition of adenylate cyclase in 
other tissues [1,6,17]; 
(ii) ‘P sites’ which inhibit adenylate cyclase at I.IM 
levels of adenosine and which are insensitive to 
methyl xanthines [ 1~31. 
The distinction between the two classes of sites was 
made in [9] on the basis of structural requirements 
for conservation of the ribose moiety of adenosine 
(R sites) or the purine moiety of adenosine (P sites). 
2’-Deoxyadenosine is a potent probe of P sites 
and will inhibit adenylate cyclase in the presence of 
GppNHp [9] a non-hydrolysable analogue of GTP 
which usually maintains a high level of adenylate 
cyclase activity [lo]. It is not clear whether GppNHp 
is displaced by 2’-deoxyadenosine. 
This work describes experiments with 2’-deoxy- 
adenosine and membranes derived from the neuro- 
blastoma X glioma hybrid cell line NG 108-l 5 which 
show that the expression of the interaction between 
the guanyl nucleoside subunit and adenylate cyclase 
is prevented by 2’-deoxyadenosine although the 
guanyl nucleoside subunit remains fully occupied by 
GPPNH~. 
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2. Experimental 
NG 108-l 5 cells were a gift from M. Nirenberg 
to D. E. Koshland jr. Cells were grown in 150 cm2 
T flasks in 5% CO2 and 95% air as in [ 111. Confluent 
cultures of cells were harvested by shaking and wash- 
ing twice in Dr harvest buffer essentially as in [ 121 
except that the homogenization buffer consisted of 
5 mM Tris-HCl (pH 7.4) and 1 mM MgCla. Mem- 
branes were further purified on a sucrose gradient 
[ 131 and were collected and stored at 70°C in 1 ml 
aliquots in a buffer of 25% sucrose, 50 mM Tris-HCl 
(pH 7.4) and 1 mM MgCla. 
Prior to use, membranes were thawed rapidly, 
washed in 30 vol. 50 mM Tris-HCl (pH 8.0), 2 mM 
MgClz and 1 mM EDTA (TME)’ and resuspended in 
the same buffer to -1 mg protein/ml. Protein con- 
centration was measured as in [ 141 using bovine 
serum albumin as standard. 
The adenylate cyclase assay mixture, at 37”C, 
contained, in 150 /.d, 50-70 c(g membrane protein, 
1 mM CAMP, 10 mM MgCla, 0.5 mM isobutylmethyl 
xanthine, 20 mM disodium creatine phosphate, 
10 units creatine kinase and 1 mM disodium [w~‘P]- 
ATP (-10 cpm/pmol) and additional ligands as 
described in figure legends. CAMP was measured 
according to [ 151. 
For preactivation, which separates the activation 
step from the cyclase assay [ 161, membranes were 
incubated with 0.1 mM GppNHp and 0.1 mM adeno- 
sine for 10 min at 37’C and washed to a IO4 dilution 
by repeated centrifugations at 38 000 X g for 10 min 
in TME (pH 8.0). 
For reversion experiments [ 16,171, which follow 
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the decay of the preactivated adenylate cyclase to 
basal activity levels, the preactivated and washed 
membranes were incubated with various ligands and 
at certain times 70 fl aliquots were removed into 
40 ~1 ice-cold 6.7 mM caffeine and 6.7 PM naloxone. 
After all aliquots were collected the assay cocktail 
was added, tubes were transfered to 37°C and CAMP 
was accumulated for 20 min. 
[o-32P] ATP and c [3H] AMP were from New 
England Nuclear, USA, GppNHp from Boehringer ,
ATP from Pierce Chemicals, 2’-deoxyadenosine from 
P and L Chemicals, CAMP, caffeine, adenosine and 
regenerating system from Sigma and isobutyl methyl 
xanthine from Aldrich. 
3. Results 
The adenylate cyclase prepared from neuro- 
blastoma X glioma hybrid cell line NC 108-l 5 is acti- 
vated by 50 FM adenosine. This activation is clearly 
inhibitable by 2’-deoxyadenosine and an R site antag- 
onist, caffeine, to the same extent (fig.la). 
When GppNHp is added a 5-fold activation of 
adenylate cyclase is observed (fig.lb). The entry of 
GppNHp to its site of action is fascile and rapid. It 
occurs independently of adenosine or caffeine and 
with no discernable lag time. Under these experi- 
mental conditions 2’-deoxyadenosine is completely 
inhibitory and adenylate cyclase remains almost at 
basal levels of activity. 
2’-Deoxyadenosine could prevent GppNHp from 
occupying the active site either by blocking the entry 
to the site or by causing the removal of GppNHp. 
Alternatively it could prevent the information 
encoded in the GppNHp subunit (N) from being 
expressed as an activation of the catalytic moiety 
of adenylate cyclase (AC). 
To test these alternatives, the adenylate cyclase 
was preactivated by GppNHp, washed extensively 
to a lo4 dilution to remove all free exchangeable 
GppNHp and exposed to various ligands to induce 
reversal to basal activity levels (fig.2). In turkey 
erythrocytes [16-l 81 these experimental conditions 
first cause GppNHp to occupy N quasi-irreversibly 
and subsequently GppNHp is dissociated from N 
[ 181 through an interaction with receptors which are 
thought to fascilitate GTP-GDP exchange [ 191. I
In NG 108-l 5 membranes the GppNHp induced 
activity remains stable to extensive washing at 0°C 
166 
1200 
_ A 
/* 
800 - 
0 / 0 
A’ h 
C 
._ 
Q) 400 
‘;; 
ifi 
E” 0 
N 
; boo0 
E 
n 
% / 
Q 2000- 
v 
J,:: 
'ooo-*/m&~~4-- 
04 
6' I I I 
0 5 10 15 20 
TIME (min) 
Fig.la. The activation of NG 108-15 membranal adenylate 
cyclase by 50 MM adenosine (a) and the inhibition of the 
adenosine response by 16.3 mM caffeine (v) or 0.4 mM 
2’deoxyadenosine (0) was followed for 20 min at 37°C. At 
the times indicated 150 ~1 aliquots were removed into 100 ~1 
2% SDS. Fig.lb CAMP accumulation in the presence of 
50 PM GppNHp: 50 PM GppNHp alone (0); 50 MM GppNHp 
and 50 PM adenosine (A); 50 PM GppNHp and 50 ctM adeno- 
sine and 16.3 mM caffeine (‘I); or 50 MM GppNHp, 50 PM 
adenosine and 0.4 mM Z’deoxyadenosine (B). 50 WM adeno- 
sine level (A) is inserted for comparison. Sampling was as in 
fig.la. 
and subsequent incubation at 37’C in the absence 
of added ligands. Adenosine at 50 PM induces very 
slight reversion. GTP (50 PM) is less effective than 
the combined effect of adenosine and GTP added 
simultaneously. 2’-Deoxyadenosine reduces the level 
of activation to below the final level obtained with 
adenosine and GTP very rapidly such that inhibition 
is complete in <30 s. Reversion by adenosine and 
GTP is much slower. Caffeine seems to activate the 
reversion as well. 
2’-Deoxyadenosine inhibition of membranes 
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Fig.2. Reversion of GppNHp and adenosine-preactivated 
membranes as induced by the following ligands: none (0); 
50 FM adenosine (a); 50 pM GTP (4); 50 ILM adenosine and 
50 PM GTP (4); 50 PM adenosine, 50 rM GTP and 16 mM 
caffeine (D); 50 rM adenosine, 50 NM GTP and 0.4 mM 
Z’deoxyadenosine (v). All the assay tubes contained 6.7 mM 
caffeine and 6.7 rM naloxone. 
preactivated by GppNHp and washed extensively 
is easily reversed by washing out 2’-deoxyadenosine 
(table 1) in cold TME and GppNHp resumes its full 
activity with no discernable ag time. Thus, it seems 
that the only effect of 2’.deoxyadenosine is to pre- 
vent the functional guanyl nucleoside subunit from 
expressing an activatory interaction with the catalytic 
moiety. 
4. Discussion 
The adenylate cyclase of NG 108-l 5 cell line is 
very similar to other membranal systems of neural 
origin f4,20], where N is also easily accessible to 
guanyl nucleotides in native washed membranes. 
But once GppNHp occupies the active site it is not 
easily removed. 
The adenosine induced activity is entirely caffeine 
sensitive and is -20% of the GppNHp activity levels 
indicating, by analogy to [ 193, that GTP-GDP 
exchange isprobably the rate limiting step of the 
catalytic activation-~activation cycle. 
The GppNHp activated state is very slowly revers- 
ible but can be enhanced by GTP and more so by 
adenosine and GTP. GTP could cause nhanced rever- 
sal by two mechanisms depending on the state of 
N to AC coupling: 
(i) If all N is coupled to AC in the presence of 
GppNHp then only an allosteric second site for 
GTP in addition to the GppNHp site would 
account for an enhancement of a monomolecular 
dissociation step such as that of GppNHp from 
the complex N - GppNHp. 
Table 1 
The effect of 2’deoxyadenosine on the stability of the GppNHp * N complex 
Additions to preactivated 
and washed membranes 
Concentration of 
additions in assay 
Net adenylate cyclase act. 
(pmol CAMP . mg-* . mm-‘) 
1 none 307 t 10 
II 0.4 mM 2’deoxyadenos~e 0.2 mM 1302 9 
III 0.4 mM 2’deoxyadenosine 0.2 mM 104rt 2 
50 MM adenosine 25 /.LM 
50 MM GTP 25 PM 
IV 0.4 mM 2’deoxyadenosine 
and washed None 28Ok 2 
NG 108-15 membranes were activated for 10 min at 37°C with 0.1 mM GppNHp and 
0.1 mM adenosine, washed to a 104-fold dilution in ice-cold TME and incubated in 
the presence (II,III) or absence (I) of 0.4 mM 2’d~xyadeno~e for 10 min at 37’C. 
2’-Deoxyadenosine was added alone (II) or in addition to 50 nM adenosine and 50 nM 
GTP (III). Only tube II containing 2’deoxyadenosine was washed in 30-fold vol. TME, 
drained, and the pellet was resuspended in TME (IV). CAMP was accumulated in all the 
tubes for 15 min at 37°C. The activity levels are net after subtraction of the basal level 
of activity. Assays were performed in duplicate 
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(ii) If, on the other hand, all N is not completely 
occupied by GppNHp at saturation, an entire 
N - GTP complex could exchange with 
N . GppNHp. 
Carefully designed reversal experiments will distin- 
guish between these two alternatives. 
2’-Deoxyadenosine inhibits adenylate cyclase 
activity under all 3 experimental conditions tested. 
But it does not cause permanent reversal of the 
GppNHp-activated adenylate cyclase as do GTP and 
adenosine [ 171. Thus the effect of 2’-deoxyadenosine 
is expressed directly at the level of catalysis, at AC. 
We now possess highly specific quantitative 
modulators of the specific concentrations of the 
3 major components of the adenylate cyclase regu- 
latory system: the receptor, which can be titrated 
by its agonist, the guanyl nucleoside subunit whose 
concentration can be limited by GppNHp, and 
the catalytic moiety whose concentration can be 
effectively reduced by ‘R site’ agonists without 
effecting N. 
Using 2’-deoxyadenosine, it is possible to design 
novel kinetic experiments which can test whether 
the guanyl-nucleoside subunit is permanently coupled 
to the catalytic moiety. 
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